Drug Shortage Report for ACH-ANASTROZOLE
Report ID | 130151 |
Drug Identification Number | 02351218 |
Brand name | ACH-ANASTROZOLE |
Common or Proper name | ANASTROZOLE |
Company Name | ACCORD HEALTHCARE INC |
Market Status | MARKETED |
Active Ingredient(s) | ANASTROZOLE |
Strength(s) | 1MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 Blister |
ATC code | L02BG |
ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-12-14 |
Actual start date | 2020-12-14 |
Estimated end date | 2021-01-11 |
Actual end date | 2021-01-20 |
Shortage status | Resolved |
Updated date | 2021-01-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2021-01-21 | French | Compare |
v4 | 2021-01-21 | English | Compare |
v3 | 2020-12-15 | English | Compare |
v2 | 2020-12-14 | French | Compare |
v1 | 2020-12-14 | English | Compare |
Showing 1 to 5 of 5